Acambis PLC: Acambis PLC announces Update on US MVA procurement
14th Nov 2006, 08:22 GMT
Cambridge, UK (MARKET WIRE)
Acambis PLC: Acambis PLC announces Update on US MVA procurement related news:
- Acambis PLC announces Update on US MVA procurement — ArriveNet : Press Releases
- SkyePharma PLC: SkyePharma PLC announces Board Appointment — Market Wire - Pharmaceuticals and Biotech
- PuriCore Plc: PuriCore Plc announces Appointment — Market Wire - Environment
- Scottish Power PLC: Scottish Power PLC announces ADS Dividend Declaration — Market Wire - Energy and Utilities
- Scottish Power PLC: Scottish Power PLC announces Interim Results — Market Wire - Energy and Utilities
- Acambis loses U.S. smallpox deal — Reuters: Shares
- PuriCore Plc announces Appointment — ArriveNet : Health
- SkyePharma PLC announces Board Appointment — ArriveNet : Press Releases
- Scottish Power PLC announces Interim Results — ArriveNet : Press Releases
- Scottish Power PLC announces ADS Dividend Declaration — ArriveNet : Press Releases
Latest news from Market Wire - Pharmaceuticals and Biotech:
- Qiagen N.V.: QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
- IBEX TECHNOLOGIES INC.: IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- Daiichi Sankyo, Inc.: First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
- Daiichi Sankyo, Inc.: WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
- Targeted Genetics Corporation: Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting
- Crucell N.V.: Crucell Announces Third Quarter 2006 Results
- SkyePharma PLC: SkyePharma PLC announces Board Appointment
- Base Technologies, Inc.: Base Technologies Award of Air Force Surgeon General Contract Continues Rapid Growth Trend
- Eugene Science, Inc.: Eugene Science Signs Major Distribution Agreement With RexGene Biotech
- GelStat Corporation: GelStat Announces the Retention of Accomplished Business Development and Marketing Firm U.S. Marketing